These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2468418)
1. Cerebrospinal fluid (CSF) investigations in migraine. Kovács K; Bors L; Tóthfalusi L; Jelencsik I; Bozsik G; Kerényi L; Komoly S Cephalalgia; 1989 Mar; 9(1):53-7. PubMed ID: 2468418 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid analyses in migraine patients and controls. Rothrock JF; Mar KR; Yaksh TL; Golbeck A; Moore AC Cephalalgia; 1995 Dec; 15(6):489-93. PubMed ID: 8706112 [TBL] [Abstract][Full Text] [Related]
3. [Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in patients with migraine during attacks and in the intercritical period]. Poloni M; Nappi G; Tartara A; Arrigo A; Bono G Boll Soc Ital Biol Sper; 1974 Jul; 50(14):1031-6. PubMed ID: 4463995 [No Abstract] [Full Text] [Related]
4. Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin. Vaughn DM; Simpson ST; Blagburn BL; Whitmer WL; Heddens-Mysinger R; Hendrix CM Vet Res Commun; 1989; 13(1):47-55. PubMed ID: 2475964 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal-fluid abnormalities associated with migraine. Day TJ; Knezevic W Med J Aust; 1984 Sep; 141(7):459-61. PubMed ID: 6472188 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. Pranzatelli MR; Huang Y; Tate E; Stanley M; Noetzel MJ; Gospe SM; Banasiak K Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417 [TBL] [Abstract][Full Text] [Related]
7. [CSF findings in patients with ALS]. Takase S Rinsho Shinkeigaku; 1984 Dec; 24(12):1257-61. PubMed ID: 6085569 [No Abstract] [Full Text] [Related]
8. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Martínez F; Castillo J; Rodríguez JR; Leira R; Noya M Cephalalgia; 1993 Apr; 13(2):89-93. PubMed ID: 8098663 [TBL] [Abstract][Full Text] [Related]
9. Hemiplegic migraine with CSF abnormalities. Motta E; Rościszewska D; Miller K Headache; 1995 Jun; 35(6):368-70. PubMed ID: 7635725 [TBL] [Abstract][Full Text] [Related]
10. [Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in patients with migraine before and after treatment with L-tryptophan]. Nappi G; Poloni M; Bono G; Savoldi F Boll Soc Ital Biol Sper; 1974 Jul; 50(14):1037-42. PubMed ID: 4463996 [No Abstract] [Full Text] [Related]
11. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves. De Ley G; De Moor A Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid 5-hydroxyindoleacetic acid level in migrainous patients during spontaneous attacks, during headache-free periods and following treatment with L-tryptophan. Poloni M; Nappi G; Arrigo A; Savoldi F Experientia; 1974 Jun; 30(6):640-1. PubMed ID: 4837086 [No Abstract] [Full Text] [Related]
17. [Levels of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid in patients with focal cerebral ischemia]. Chavko M; Kehr J; Vasková M; Eiben E Cesk Neurol Neurochir; 1989 Oct; 52(6):403-8. PubMed ID: 2483951 [TBL] [Abstract][Full Text] [Related]
18. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF). Sourkes TL; Young SN; Garelis E; Lal S Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132 [TBL] [Abstract][Full Text] [Related]
19. [Migraine manifestations and lymphocyte pleocytosis of the cerebrospinal fluid]. Liblau R; Roualdes B; Degos JD Ann Med Interne (Paris); 1987; 138(4):291-5. PubMed ID: 3631829 [TBL] [Abstract][Full Text] [Related]
20. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. Stuerenburg HJ; Ganzer S; Müller-Thomsen T Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]